Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease.
A private investor, with a focus on volatility, market sentiment, technical analysis, and ETFs. I author the VIX and More blog, a newsletter, and am one the founders of Expiring Monthly: The Options Traders Journal.
Michael Bigger is an investor and a trader who has been involved with trading technologies for more than twenty years. He runs the Bigger Capital Fund, LP and he manages money for many institutional investors.